Literature DB >> 10201933

Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108.

A Yamada1, K Kubo, T Takeshita, N Harashima, K Kawano, T Mine, K Sagawa, K Sugamura, K Itoh.   

Abstract

CDw108, also known as the John-Milton-Hagen human blood group Ag, is an 80-kDa glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein that is preferentially expressed on activated lymphocytes and E. The molecular characteristics and biological function of the CDw108 were not clarified previously. In this manuscript, we identify the cDNA clone containing the entire coding sequence of the CDw108 gene and report its molecular characteristics. The 1998-base pairs of the open reading frame of the cloned cDNA encoded a protein of 666 amino acids (aa), including the 46 aa of the signal peptide and the 19 aa of the GPI-anchor motif. Thus, the membrane-anchoring form of CDw108 was the 602 aa, and the estimated molecular mass of the unglycosylated form was 68 kDa. The RGD (Arg-Gly-Asp) cell attachment sequence and the five potential N-linked glycosylation sites were located on the membrane-anchoring form. Flow cytometric and immunoprecipitation analyses of the CDw108 cDNA transfectants confirmed that the cloned cDNA encoded the native form of CDw108. The CDw108 mRNA was expressed in activated PBMCs as well as in the spleen, thymus, testis, placenta, and brain, but was not expressed in any other tissues tested. Radiation hybrid mapping indicated that the CDw108 gene was located in the middle of the long arm of chromosome 15 (15q23-24). This molecular information will be critical for understanding the biological function of the CDw108 Ag.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201933

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

2.  Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1.

Authors:  Heli Liu; Z Sean Juo; Ann Hye-Ryong Shim; Pamela J Focia; Xiaoyan Chen; K Christopher Garcia; Xiaolin He
Journal:  Cell       Date:  2010-08-19       Impact factor: 41.582

Review 3.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

4.  Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.

Authors:  Joshua Ghofrani; Olivier Lucar; Haley Dugan; R Keith Reeves; Stephanie Jost
Journal:  Eur J Immunol       Date:  2019-05-02       Impact factor: 5.532

5.  Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis.

Authors:  Ana Gutiérrez-Franco; Herena Eixarch; Carme Costa; Vanessa Gil; Mireia Castillo; Laura Calvo-Barreiro; Xavier Montalban; José A Del Río; Carmen Espejo
Journal:  Mol Neurobiol       Date:  2016-10-06       Impact factor: 5.590

6.  Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis.

Authors:  Anguraj Sadanandam; Erin G Rosenbaugh; Seema Singh; Michelle Varney; Rakesh K Singh
Journal:  Microvasc Res       Date:  2009-10-19       Impact factor: 3.514

7.  Semaphorin 7A in circulating regulatory T cells is increased in autosomal-dominant polycystic kidney disease and decreases with tolvaptan treatment.

Authors:  Yashang Lee; Katrina Lehmann Blount; Feng Dai; Siobhan Thompson; Jonathan Kaufman Scher; Sherrie Bitterman; Madeline Droher; Erica L Herzog; Gilbert Moeckel; Anil Karihaloo; Neera K Dahl
Journal:  Clin Exp Nephrol       Date:  2018-02-16       Impact factor: 2.801

8.  Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.

Authors:  Alan M Elder; Beth A J Tamburini; Lyndsey S Crump; Sarah A Black; Veronica M Wessells; Pepper J Schedin; Virginia F Borges; Traci R Lyons
Journal:  Cancer Res       Date:  2018-09-25       Impact factor: 12.701

Review 9.  Semaphorin7A: branching beyond axonal guidance and into immunity.

Authors:  Ramon Garcia-Areas; Stephania Libreros; Vijaya Iragavarapu-Charyulu
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

10.  Semaphorin-7A is an erythrocyte receptor for P. falciparum merozoite-specific TRAP homolog, MTRAP.

Authors:  S Josefin Bartholdson; Leyla Y Bustamante; Cecile Crosnier; Steven Johnson; Susan Lea; Julian C Rayner; Gavin J Wright
Journal:  PLoS Pathog       Date:  2012-11-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.